Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...
A research team presents an overview of recent advances in the microbial biosynthesis of L-tryptophan (L-Trp) and its ...
AZoLifeSciences on MSN
Synthetic biology and metabolic engineering drive microbial L-tryptophan biomanufacturing
This review synthesizes progress in pathway optimization, regulatory rewiring, and microbial cell factory design that has ...
3d
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine
Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...
Discover how much a pet wellness plan could save you.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback